Global Veterinary Peptide Products Market Growth (Status and Outlook) 2026-2032

May 2026 | 94 pages | ID: G965F27EB29EEN
LP Information

Abstracts

The global Veterinary Peptide Products market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032.

United States market for Veterinary Peptide Products is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

China market for Veterinary Peptide Products is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

Europe market for Veterinary Peptide Products is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

Global key Veterinary Peptide Products players cover AmbioPharm, Zoetis, Ceva Corporate, Huvepharma, Lifecome Biochemistry, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.

LPI (LP Information)' newest research report, the “Veterinary Peptide Products Industry Forecast” looks at past sales and reviews total world Veterinary Peptide Products sales in 2025, providing a comprehensive analysis by region and market sector of projected Veterinary Peptide Products sales for 2026 through 2032. With Veterinary Peptide Products sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Veterinary Peptide Products industry.

This Insight Report provides a comprehensive analysis of the global Veterinary Peptide Products landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Veterinary Peptide Products portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Veterinary Peptide Products market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Veterinary Peptide Products and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Veterinary Peptide Products.

This report presents a comprehensive overview, market shares, and growth opportunities of Veterinary Peptide Products market by product type, application, key players and key regions and countries.

Segmentation by Type:

• Oxytocin
• Gonadorelin
• Buserelin
• Veterinary Bacitracin Zinc
• Others

Segmentation by Application:

• Pig
• Ox
• Sheep
• Others

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• AmbioPharm
• Zoetis
• Ceva Corporate
• Huvepharma
• Lifecome Biochemistry
• Qilu Pharmaceutical
• Orion Animal Nutrition
• Vega Pharma
• Tianjin Xinxing Veterinary Pharmaceutical
• Shenzhen Jianyuan Pharmaceutical Technology Co., Ltd.

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Veterinary Peptide Products Market Size (2021-2032)
  2.1.2 Veterinary Peptide Products Market Size CAGR by Region (2021 VS 2025 VS 2032)
  2.1.3 World Current & Future Analysis for Veterinary Peptide Products by Country/Region (2021, 2025 & 2032)
2.2 Veterinary Peptide Products Segment by Type
  2.2.1 Oxytocin
  2.2.2 Gonadorelin
  2.2.3 Buserelin
  2.2.4 Veterinary Bacitracin Zinc
  2.2.5 Others
  2.2.6 Veterinary Peptide Products Market Size by Type
    2.2.6.1 Veterinary Peptide Products Market Size CAGR by Type (2021 VS 2025 VS 2032)
    2.2.6.2 Global Veterinary Peptide Products Market Size Market Share by Type (2021-2026)
2.3 Veterinary Peptide Products Segment by Application
  2.3.1 Pig
  2.3.2 Ox
  2.3.3 Sheep
  2.3.4 Others
  2.3.5 Veterinary Peptide Products Market Size by Application
    2.3.5.1 Veterinary Peptide Products Market Size CAGR by Application (2021 VS 2025 VS 2032)
    2.3.5.2 Global Veterinary Peptide Products Market Size Market Share by Application (2021-2026)

3 VETERINARY PEPTIDE PRODUCTS MARKET SIZE BY PLAYER

3.1 Veterinary Peptide Products Market Size Market Share by Player
  3.1.1 Global Veterinary Peptide Products Revenue by Player (2021-2026)
  3.1.2 Global Veterinary Peptide Products Revenue Market Share by Player (2021-2026)
3.2 Global Veterinary Peptide Products Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 VETERINARY PEPTIDE PRODUCTS BY REGION

4.1 Veterinary Peptide Products Market Size by Region (2021-2026)
4.2 Global Veterinary Peptide Products Annual Revenue by Country/Region (2021-2026)
4.3 Americas Veterinary Peptide Products Market Size Growth (2021-2026)
4.4 APAC Veterinary Peptide Products Market Size Growth (2021-2026)
4.5 Europe Veterinary Peptide Products Market Size Growth (2021-2026)
4.6 Middle East & Africa Veterinary Peptide Products Market Size Growth (2021-2026)

5 AMERICAS

5.1 Americas Veterinary Peptide Products Market Size by Country (2021-2026)
5.2 Americas Veterinary Peptide Products Market Size by Type (2021-2026)
5.3 Americas Veterinary Peptide Products Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Veterinary Peptide Products Market Size by Region (2021-2026)
6.2 APAC Veterinary Peptide Products Market Size by Type (2021-2026)
6.3 APAC Veterinary Peptide Products Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Veterinary Peptide Products Market Size by Country (2021-2026)
7.2 Europe Veterinary Peptide Products Market Size by Type (2021-2026)
7.3 Europe Veterinary Peptide Products Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Veterinary Peptide Products by Region (2021-2026)
8.2 Middle East & Africa Veterinary Peptide Products Market Size by Type (2021-2026)
8.3 Middle East & Africa Veterinary Peptide Products Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL VETERINARY PEPTIDE PRODUCTS MARKET FORECAST

10.1 Global Veterinary Peptide Products Forecast by Region (2027-2032)
  10.1.1 Global Veterinary Peptide Products Forecast by Region (2027-2032)
  10.1.2 Americas Veterinary Peptide Products Forecast
  10.1.3 APAC Veterinary Peptide Products Forecast
  10.1.4 Europe Veterinary Peptide Products Forecast
  10.1.5 Middle East & Africa Veterinary Peptide Products Forecast
10.2 Americas Veterinary Peptide Products Forecast by Country (2027-2032)
  10.2.1 United States Market Veterinary Peptide Products Forecast
  10.2.2 Canada Market Veterinary Peptide Products Forecast
  10.2.3 Mexico Market Veterinary Peptide Products Forecast
  10.2.4 Brazil Market Veterinary Peptide Products Forecast
10.3 APAC Veterinary Peptide Products Forecast by Region (2027-2032)
  10.3.1 China Veterinary Peptide Products Market Forecast
  10.3.2 Japan Market Veterinary Peptide Products Forecast
  10.3.3 Korea Market Veterinary Peptide Products Forecast
  10.3.4 Southeast Asia Market Veterinary Peptide Products Forecast
  10.3.5 India Market Veterinary Peptide Products Forecast
  10.3.6 Australia Market Veterinary Peptide Products Forecast
10.4 Europe Veterinary Peptide Products Forecast by Country (2027-2032)
  10.4.1 Germany Market Veterinary Peptide Products Forecast
  10.4.2 France Market Veterinary Peptide Products Forecast
  10.4.3 UK Market Veterinary Peptide Products Forecast
  10.4.4 Italy Market Veterinary Peptide Products Forecast
  10.4.5 Russia Market Veterinary Peptide Products Forecast
10.5 Middle East & Africa Veterinary Peptide Products Forecast by Region (2027-2032)
  10.5.1 Egypt Market Veterinary Peptide Products Forecast
  10.5.2 South Africa Market Veterinary Peptide Products Forecast
  10.5.3 Israel Market Veterinary Peptide Products Forecast
  10.5.4 Turkey Market Veterinary Peptide Products Forecast
10.6 Global Veterinary Peptide Products Forecast by Type (2027-2032)
10.7 Global Veterinary Peptide Products Forecast by Application (2027-2032)
  10.7.1 GCC Countries Market Veterinary Peptide Products Forecast

11 KEY PLAYERS ANALYSIS

11.1 AmbioPharm
  11.1.1 AmbioPharm Company Information
  11.1.2 AmbioPharm Veterinary Peptide Products Product Offered
  11.1.3 AmbioPharm Veterinary Peptide Products Revenue, Gross Margin and Market Share (2021-2026)
  11.1.4 AmbioPharm Main Business Overview
  11.1.5 AmbioPharm Latest Developments
11.2 Zoetis
  11.2.1 Zoetis Company Information
  11.2.2 Zoetis Veterinary Peptide Products Product Offered
  11.2.3 Zoetis Veterinary Peptide Products Revenue, Gross Margin and Market Share (2021-2026)
  11.2.4 Zoetis Main Business Overview
  11.2.5 Zoetis Latest Developments
11.3 Ceva Corporate
  11.3.1 Ceva Corporate Company Information
  11.3.2 Ceva Corporate Veterinary Peptide Products Product Offered
  11.3.3 Ceva Corporate Veterinary Peptide Products Revenue, Gross Margin and Market Share (2021-2026)
  11.3.4 Ceva Corporate Main Business Overview
  11.3.5 Ceva Corporate Latest Developments
11.4 Huvepharma
  11.4.1 Huvepharma Company Information
  11.4.2 Huvepharma Veterinary Peptide Products Product Offered
  11.4.3 Huvepharma Veterinary Peptide Products Revenue, Gross Margin and Market Share (2021-2026)
  11.4.4 Huvepharma Main Business Overview
  11.4.5 Huvepharma Latest Developments
11.5 Lifecome Biochemistry
  11.5.1 Lifecome Biochemistry Company Information
  11.5.2 Lifecome Biochemistry Veterinary Peptide Products Product Offered
  11.5.3 Lifecome Biochemistry Veterinary Peptide Products Revenue, Gross Margin and Market Share (2021-2026)
  11.5.4 Lifecome Biochemistry Main Business Overview
  11.5.5 Lifecome Biochemistry Latest Developments
11.6 Qilu Pharmaceutical
  11.6.1 Qilu Pharmaceutical Company Information
  11.6.2 Qilu Pharmaceutical Veterinary Peptide Products Product Offered
  11.6.3 Qilu Pharmaceutical Veterinary Peptide Products Revenue, Gross Margin and Market Share (2021-2026)
  11.6.4 Qilu Pharmaceutical Main Business Overview
  11.6.5 Qilu Pharmaceutical Latest Developments
11.7 Orion Animal Nutrition
  11.7.1 Orion Animal Nutrition Company Information
  11.7.2 Orion Animal Nutrition Veterinary Peptide Products Product Offered
  11.7.3 Orion Animal Nutrition Veterinary Peptide Products Revenue, Gross Margin and Market Share (2021-2026)
  11.7.4 Orion Animal Nutrition Main Business Overview
  11.7.5 Orion Animal Nutrition Latest Developments
11.8 Vega Pharma
  11.8.1 Vega Pharma Company Information
  11.8.2 Vega Pharma Veterinary Peptide Products Product Offered
  11.8.3 Vega Pharma Veterinary Peptide Products Revenue, Gross Margin and Market Share (2021-2026)
  11.8.4 Vega Pharma Main Business Overview
  11.8.5 Vega Pharma Latest Developments
11.9 Tianjin Xinxing Veterinary Pharmaceutical
  11.9.1 Tianjin Xinxing Veterinary Pharmaceutical Company Information
  11.9.2 Tianjin Xinxing Veterinary Pharmaceutical Veterinary Peptide Products Product Offered
  11.9.3 Tianjin Xinxing Veterinary Pharmaceutical Veterinary Peptide Products Revenue, Gross Margin and Market Share (2021-2026)
  11.9.4 Tianjin Xinxing Veterinary Pharmaceutical Main Business Overview
  11.9.5 Tianjin Xinxing Veterinary Pharmaceutical Latest Developments
11.10 Shenzhen Jianyuan Pharmaceutical Technology Co., Ltd.
  11.10.1 Shenzhen Jianyuan Pharmaceutical Technology Co., Ltd. Company Information
  11.10.2 Shenzhen Jianyuan Pharmaceutical Technology Co., Ltd. Veterinary Peptide Products Product Offered
  11.10.3 Shenzhen Jianyuan Pharmaceutical Technology Co., Ltd. Veterinary Peptide Products Revenue, Gross Margin and Market Share (2021-2026)
  11.10.4 Shenzhen Jianyuan Pharmaceutical Technology Co., Ltd. Main Business Overview
  11.10.5 Shenzhen Jianyuan Pharmaceutical Technology Co., Ltd. Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Veterinary Peptide Products Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Veterinary Peptide Products Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Oxytocin
Table 4. Major Players of Gonadorelin
Table 5. Major Players of Buserelin
Table 6. Major Players of Veterinary Bacitracin Zinc
Table 7. Major Players of Others
Table 8. Veterinary Peptide Products Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 9. Global Veterinary Peptide Products Market Size by Type (2021-2026) & ($ millions)
Table 10. Global Veterinary Peptide Products Market Size Market Share by Type (2021-2026)
Table 11. Veterinary Peptide Products Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 12. Global Veterinary Peptide Products Market Size by Application (2021-2026) & ($ millions)
Table 13. Global Veterinary Peptide Products Market Size Market Share by Application (2021-2026)
Table 14. Global Veterinary Peptide Products Revenue by Player (2021-2026) & ($ millions)
Table 15. Global Veterinary Peptide Products Revenue Market Share by Player (2021-2026)
Table 16. Veterinary Peptide Products Key Players Head office and Products Offered
Table 17. Veterinary Peptide Products Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 18. New Products and Potential Entrants
Table 19. Mergers & Acquisitions, Expansion
Table 20. Global Veterinary Peptide Products Market Size by Region (2021-2026) & ($ millions)
Table 21. Global Veterinary Peptide Products Market Size Market Share by Region (2021-2026)
Table 22. Global Veterinary Peptide Products Revenue by Country/Region (2021-2026) & ($ millions)
Table 23. Global Veterinary Peptide Products Revenue Market Share by Country/Region (2021-2026)
Table 24. Americas Veterinary Peptide Products Market Size by Country (2021-2026) & ($ millions)
Table 25. Americas Veterinary Peptide Products Market Size Market Share by Country (2021-2026)
Table 26. Americas Veterinary Peptide Products Market Size by Type (2021-2026) & ($ millions)
Table 27. Americas Veterinary Peptide Products Market Size Market Share by Type (2021-2026)
Table 28. Americas Veterinary Peptide Products Market Size by Application (2021-2026) & ($ millions)
Table 29. Americas Veterinary Peptide Products Market Size Market Share by Application (2021-2026)
Table 30. APAC Veterinary Peptide Products Market Size by Region (2021-2026) & ($ millions)
Table 31. APAC Veterinary Peptide Products Market Size Market Share by Region (2021-2026)
Table 32. APAC Veterinary Peptide Products Market Size by Type (2021-2026) & ($ millions)
Table 33. APAC Veterinary Peptide Products Market Size by Application (2021-2026) & ($ millions)
Table 34. Europe Veterinary Peptide Products Market Size by Country (2021-2026) & ($ millions)
Table 35. Europe Veterinary Peptide Products Market Size Market Share by Country (2021-2026)
Table 36. Europe Veterinary Peptide Products Market Size by Type (2021-2026) & ($ millions)
Table 37. Europe Veterinary Peptide Products Market Size by Application (2021-2026) & ($ millions)
Table 38. Middle East & Africa Veterinary Peptide Products Market Size by Region (2021-2026) & ($ millions)
Table 39. Middle East & Africa Veterinary Peptide Products Market Size by Type (2021-2026) & ($ millions)
Table 40. Middle East & Africa Veterinary Peptide Products Market Size by Application (2021-2026) & ($ millions)
Table 41. Key Market Drivers & Growth Opportunities of Veterinary Peptide Products
Table 42. Key Market Challenges & Risks of Veterinary Peptide Products
Table 43. Key Industry Trends of Veterinary Peptide Products
Table 44. Global Veterinary Peptide Products Market Size Forecast by Region (2027-2032) & ($ millions)
Table 45. Global Veterinary Peptide Products Market Size Market Share Forecast by Region (2027-2032)
Table 46. Global Veterinary Peptide Products Market Size Forecast by Type (2027-2032) & ($ millions)
Table 47. Global Veterinary Peptide Products Market Size Forecast by Application (2027-2032) & ($ millions)
Table 48. AmbioPharm Details, Company Type, Veterinary Peptide Products Area Served and Its Competitors
Table 49. AmbioPharm Veterinary Peptide Products Product Offered
Table 50. AmbioPharm Veterinary Peptide Products Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 51. AmbioPharm Main Business
Table 52. AmbioPharm Latest Developments
Table 53. Zoetis Details, Company Type, Veterinary Peptide Products Area Served and Its Competitors
Table 54. Zoetis Veterinary Peptide Products Product Offered
Table 55. Zoetis Veterinary Peptide Products Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 56. Zoetis Main Business
Table 57. Zoetis Latest Developments
Table 58. Ceva Corporate Details, Company Type, Veterinary Peptide Products Area Served and Its Competitors
Table 59. Ceva Corporate Veterinary Peptide Products Product Offered
Table 60. Ceva Corporate Veterinary Peptide Products Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 61. Ceva Corporate Main Business
Table 62. Ceva Corporate Latest Developments
Table 63. Huvepharma Details, Company Type, Veterinary Peptide Products Area Served and Its Competitors
Table 64. Huvepharma Veterinary Peptide Products Product Offered
Table 65. Huvepharma Veterinary Peptide Products Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 66. Huvepharma Main Business
Table 67. Huvepharma Latest Developments
Table 68. Lifecome Biochemistry Details, Company Type, Veterinary Peptide Products Area Served and Its Competitors
Table 69. Lifecome Biochemistry Veterinary Peptide Products Product Offered
Table 70. Lifecome Biochemistry Veterinary Peptide Products Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 71. Lifecome Biochemistry Main Business
Table 72. Lifecome Biochemistry Latest Developments
Table 73. Qilu Pharmaceutical Details, Company Type, Veterinary Peptide Products Area Served and Its Competitors
Table 74. Qilu Pharmaceutical Veterinary Peptide Products Product Offered
Table 75. Qilu Pharmaceutical Veterinary Peptide Products Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 76. Qilu Pharmaceutical Main Business
Table 77. Qilu Pharmaceutical Latest Developments
Table 78. Orion Animal Nutrition Details, Company Type, Veterinary Peptide Products Area Served and Its Competitors
Table 79. Orion Animal Nutrition Veterinary Peptide Products Product Offered
Table 80. Orion Animal Nutrition Veterinary Peptide Products Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 81. Orion Animal Nutrition Main Business
Table 82. Orion Animal Nutrition Latest Developments
Table 83. Vega Pharma Details, Company Type, Veterinary Peptide Products Area Served and Its Competitors
Table 84. Vega Pharma Veterinary Peptide Products Product Offered
Table 85. Vega Pharma Veterinary Peptide Products Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 86. Vega Pharma Main Business
Table 87. Vega Pharma Latest Developments
Table 88. Tianjin Xinxing Veterinary Pharmaceutical Details, Company Type, Veterinary Peptide Products Area Served and Its Competitors
Table 89. Tianjin Xinxing Veterinary Pharmaceutical Veterinary Peptide Products Product Offered
Table 90. Tianjin Xinxing Veterinary Pharmaceutical Veterinary Peptide Products Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 91. Tianjin Xinxing Veterinary Pharmaceutical Main Business
Table 92. Tianjin Xinxing Veterinary Pharmaceutical Latest Developments
Table 93. Shenzhen Jianyuan Pharmaceutical Technology Co., Ltd. Details, Company Type, Veterinary Peptide Products Area Served and Its Competitors
Table 94. Shenzhen Jianyuan Pharmaceutical Technology Co., Ltd. Veterinary Peptide Products Product Offered
Table 95. Shenzhen Jianyuan Pharmaceutical Technology Co., Ltd. Veterinary Peptide Products Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 96. Shenzhen Jianyuan Pharmaceutical Technology Co., Ltd. Main Business
Table 97. Shenzhen Jianyuan Pharmaceutical Technology Co., Ltd. Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Veterinary Peptide Products Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Veterinary Peptide Products Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Veterinary Peptide Products Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Veterinary Peptide Products Sales Market Share by Country/Region (2025)
Figure 8. Veterinary Peptide Products Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Veterinary Peptide Products Market Size Market Share by Type in 2025
Figure 10. Veterinary Peptide Products in Pig
Figure 11. Global Veterinary Peptide Products Market: Pig (2021-2026) & ($ millions)
Figure 12. Veterinary Peptide Products in Ox
Figure 13. Global Veterinary Peptide Products Market: Ox (2021-2026) & ($ millions)
Figure 14. Veterinary Peptide Products in Sheep
Figure 15. Global Veterinary Peptide Products Market: Sheep (2021-2026) & ($ millions)
Figure 16. Veterinary Peptide Products in Others
Figure 17. Global Veterinary Peptide Products Market: Others (2021-2026) & ($ millions)
Figure 18. Global Veterinary Peptide Products Market Size Market Share by Application in 2025
Figure 19. Global Veterinary Peptide Products Revenue Market Share by Player in 2025
Figure 20. Global Veterinary Peptide Products Market Size Market Share by Region (2021-2026)
Figure 21. Americas Veterinary Peptide Products Market Size 2021-2026 ($ millions)
Figure 22. APAC Veterinary Peptide Products Market Size 2021-2026 ($ millions)
Figure 23. Europe Veterinary Peptide Products Market Size 2021-2026 ($ millions)
Figure 24. Middle East & Africa Veterinary Peptide Products Market Size 2021-2026 ($ millions)
Figure 25. Americas Veterinary Peptide Products Value Market Share by Country in 2025
Figure 26. United States Veterinary Peptide Products Market Size Growth 2021-2026 ($ millions)
Figure 27. Canada Veterinary Peptide Products Market Size Growth 2021-2026 ($ millions)
Figure 28. Mexico Veterinary Peptide Products Market Size Growth 2021-2026 ($ millions)
Figure 29. Brazil Veterinary Peptide Products Market Size Growth 2021-2026 ($ millions)
Figure 30. APAC Veterinary Peptide Products Market Size Market Share by Region in 2025
Figure 31. APAC Veterinary Peptide Products Market Size Market Share by Type (2021-2026)
Figure 32. APAC Veterinary Peptide Products Market Size Market Share by Application (2021-2026)
Figure 33. China Veterinary Peptide Products Market Size Growth 2021-2026 ($ millions)
Figure 34. Japan Veterinary Peptide Products Market Size Growth 2021-2026 ($ millions)
Figure 35. South Korea Veterinary Peptide Products Market Size Growth 2021-2026 ($ millions)
Figure 36. Southeast Asia Veterinary Peptide Products Market Size Growth 2021-2026 ($ millions)
Figure 37. India Veterinary Peptide Products Market Size Growth 2021-2026 ($ millions)
Figure 38. Australia Veterinary Peptide Products Market Size Growth 2021-2026 ($ millions)
Figure 39. Europe Veterinary Peptide Products Market Size Market Share by Country in 2025
Figure 40. Europe Veterinary Peptide Products Market Size Market Share by Type (2021-2026)
Figure 41. Europe Veterinary Peptide Products Market Size Market Share by Application (2021-2026)
Figure 42. Germany Veterinary Peptide Products Market Size Growth 2021-2026 ($ millions)
Figure 43. France Veterinary Peptide Products Market Size Growth 2021-2026 ($ millions)
Figure 44. UK Veterinary Peptide Products Market Size Growth 2021-2026 ($ millions)
Figure 45. Italy Veterinary Peptide Products Market Size Growth 2021-2026 ($ millions)
Figure 46. Russia Veterinary Peptide Products Market Size Growth 2021-2026 ($ millions)
Figure 47. Middle East & Africa Veterinary Peptide Products Market Size Market Share by Region (2021-2026)
Figure 48. Middle East & Africa Veterinary Peptide Products Market Size Market Share by Type (2021-2026)
Figure 49. Middle East & Africa Veterinary Peptide Products Market Size Market Share by Application (2021-2026)
Figure 50. Egypt Veterinary Peptide Products Market Size Growth 2021-2026 ($ millions)
Figure 51. South Africa Veterinary Peptide Products Market Size Growth 2021-2026 ($ millions)
Figure 52. Israel Veterinary Peptide Products Market Size Growth 2021-2026 ($ millions)
Figure 53. Turkey Veterinary Peptide Products Market Size Growth 2021-2026 ($ millions)
Figure 54. GCC Countries Veterinary Peptide Products Market Size Growth 2021-2026 ($ millions)
Figure 55. Americas Veterinary Peptide Products Market Size 2027-2032 ($ millions)
Figure 56. APAC Veterinary Peptide Products Market Size 2027-2032 ($ millions)
Figure 57. Europe Veterinary Peptide Products Market Size 2027-2032 ($ millions)
Figure 58. Middle East & Africa Veterinary Peptide Products Market Size 2027-2032 ($ millions)
Figure 59. United States Veterinary Peptide Products Market Size 2027-2032 ($ millions)
Figure 60. Canada Veterinary Peptide Products Market Size 2027-2032 ($ millions)
Figure 61. Mexico Veterinary Peptide Products Market Size 2027-2032 ($ millions)
Figure 62. Brazil Veterinary Peptide Products Market Size 2027-2032 ($ millions)
Figure 63. China Veterinary Peptide Products Market Size 2027-2032 ($ millions)
Figure 64. Japan Veterinary Peptide Products Market Size 2027-2032 ($ millions)
Figure 65. Korea Veterinary Peptide Products Market Size 2027-2032 ($ millions)
Figure 66. Southeast Asia Veterinary Peptide Products Market Size 2027-2032 ($ millions)
Figure 67. India Veterinary Peptide Products Market Size 2027-2032 ($ millions)
Figure 68. Australia Veterinary Peptide Products Market Size 2027-2032 ($ millions)
Figure 69. Germany Veterinary Peptide Products Market Size 2027-2032 ($ millions)
Figure 70. France Veterinary Peptide Products Market Size 2027-2032 ($ millions)
Figure 71. UK Veterinary Peptide Products Market Size 2027-2032 ($ millions)
Figure 72. Italy Veterinary Peptide Products Market Size 2027-2032 ($ millions)
Figure 73. Russia Veterinary Peptide Products Market Size 2027-2032 ($ millions)
Figure 74. Egypt Veterinary Peptide Products Market Size 2027-2032 ($ millions)
Figure 75. South Africa Veterinary Peptide Products Market Size 2027-2032 ($ millions)
Figure 76. Israel Veterinary Peptide Products Market Size 2027-2032 ($ millions)
Figure 77. Turkey Veterinary Peptide Products Market Size 2027-2032 ($ millions)
Figure 78. Global Veterinary Peptide Products Market Size Market Share Forecast by Type (2027-2032)
Figure 79. Global Veterinary Peptide Products Market Size Market Share Forecast by Application (2027-2032)
Figure 80. GCC Countries Veterinary Peptide Products Market Size 2027-2032 ($ millions)